{"id":24995,"date":"2025-12-04T11:27:19","date_gmt":"2025-12-04T11:27:19","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=24995"},"modified":"2025-12-04T11:27:19","modified_gmt":"2025-12-04T11:27:19","slug":"meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/","title":{"rendered":"\u660e\u6cbb\u88fd\u83d3\u3001\u30ea\u30ea\u30c3\u30af\u30d0\u30a4\u30aa\u306e\u30a4\u30b0\u88fd\u9020\u3092\u652f\u63f4"},"content":{"rendered":"

Meiji Seika Pharma Co., Ltd. announced a strategic equity investment in Lyric Bio, Inc. Through this investment, Meiji Seika Pharma seeks to accelerate the early-stage development of Lyric Bio’s innovative platform for producing human immunoglobulin (IVIg), explore donation-independent manufacturing methods, and lay the groundwork for a more resilient, high-quality supply of plasma-derived therapeutics to meet increasing global demand.<\/p>

Lyric Bio is developing a next-generation biomanufacturing platform for IVIg production. The company’s approach uses tissue-mimicking bioreactors built on a proprietary laser-printed cellular substrate that enables ultra high-density cell growth and has the potential to deliver more than 1,000 IVIg doses from a single donor.<\/p>

This investment will accelerate Lyric Bio’s ongoing R&D activities and implementation of its IVIg manufacturing platform, strengthening the cooperative relationship between Meiji Seika Pharma and Lyric Bio.<\/p>

\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a \u30cc\u30de\u30d6\u3068\u79d1\u7814\u88fd\u85ac\u3001IBD\u6cbb\u7642\u85acNM81\u306e\u958b\u767a\u3067\u63d0\u643a<\/a><\/h4>

“We’re thrilled to collaborate with Meiji<\/a> in driving innovation for IVIg,” said Kayj Shannon, CEO of Lyric Bio. “Their deep expertise and support will be instrumental in helping us lower costs, broaden access, and decrease its dependence on human donors.”<\/p>

\u30bd\u30fc\u30b9 BusinessWire<\/a><\/strong><\/p>","protected":false},"excerpt":{"rendered":"

Meiji Seika Pharma Co., Ltd. announced a strategic equity investment in Lyric Bio, Inc. Through this investment, Meiji Seika Pharma seeks to accelerate the early-stage development of Lyric Bio’s innovative platform for producing human immunoglobulin (IVIg), explore donation-independent manufacturing methods, and lay the groundwork for a more resilient, high-quality supply of plasma-derived therapeutics to meet increasing global demand.Lyric Bio is developing a next-generation biomanufacturing platform for IVIg production. The company’s approach uses tissue-mimicking bioreactors built on a proprietary laser-printed cellular substrate that enables ultra high-density cell growth and has the potential to deliver more than 1,000 IVIg doses from a single donor.This investment will accelerate Lyric Bio’s ongoing R&D activities […]<\/p>\n","protected":false},"author":4,"featured_media":24996,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,181,89,211,237,182,206],"tags":[150,9556,346,9555,424],"ppma_author":[205],"class_list":["post-24995","post","type-post","status-publish","format-standard","has-post-thumbnail","category-apac","category-biotech","category-health-tech","category-japan","category-news","category-pharma","category-regional","tag-biotech","tag-lyric-bio","tag-manufacturing","tag-meiji-seika-pharma","tag-pharma"],"yoast_head":"\nMeiji Seika Pharma Invests in Lyric Bio\u2019s Ig Manufacturing<\/title>\n<meta name=\"description\" content=\"Meiji Seika Pharma makes a strategic equity investment in Lyric Bio, supporting next-generation human immunoglobulin manufacturing.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Meiji Seika Pharma Invests in Lyric Bio\u2019s Ig Manufacturing\" \/>\n<meta property=\"og:description\" content=\"Meiji Seika Pharma makes a strategic equity investment in Lyric Bio, supporting next-generation human immunoglobulin manufacturing.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-04T11:27:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/12\/Meiji-Seika-Pharma-Invests-in-Lyric-Bio-for-Next-Generation-Human-Immunoglobulin-Manufacturing.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NewsDesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"NewsDesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u660e\u6cbb\u88fd\u83d3\u3001\u30ea\u30ea\u30c3\u30af\u30d0\u30a4\u30aa\u306e\u30a4\u30b0\u88fd\u9020\u306b\u51fa\u8cc7","description":"\u660e\u6cbb\u88fd\u83d3\u304c\u30ea\u30ea\u30c3\u30af\u30d0\u30a4\u30aa\u306b\u6226\u7565\u7684\u8cc7\u672c\u53c2\u52a0\u3001\u6b21\u4e16\u4ee3\u30d2\u30c8\u514d\u75ab\u30b0\u30ed\u30d6\u30ea\u30f3\u88fd\u9020\u3092\u652f\u63f4.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/","og_locale":"ja_JP","og_type":"article","og_title":"Meiji Seika Pharma Invests in Lyric Bio\u2019s Ig Manufacturing","og_description":"Meiji Seika Pharma makes a strategic equity investment in Lyric Bio, supporting next-generation human immunoglobulin manufacturing.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/","og_site_name":"itbusinesstoday","article_published_time":"2025-12-04T11:27:19+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/12\/Meiji-Seika-Pharma-Invests-in-Lyric-Bio-for-Next-Generation-Human-Immunoglobulin-Manufacturing.webp","type":"image\/webp"}],"author":"NewsDesk","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"NewsDesk","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/"},"author":{"name":"NewsDesk","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812"},"headline":"Meiji Seika Pharma Supports Lyric Bio in Ig Manufacturing","datePublished":"2025-12-04T11:27:19+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/"},"wordCount":197,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/12\/Meiji-Seika-Pharma-Invests-in-Lyric-Bio-for-Next-Generation-Human-Immunoglobulin-Manufacturing.webp","keywords":["Biotech","Lyric Bio","Manufacturing","Meiji Seika Pharma","Pharma"],"articleSection":["APAC","Biotech","Health Tech","Japan","News","Pharma","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/","name":"\u660e\u6cbb\u88fd\u83d3\u3001\u30ea\u30ea\u30c3\u30af\u30d0\u30a4\u30aa\u306e\u30a4\u30b0\u88fd\u9020\u306b\u51fa\u8cc7","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/12\/Meiji-Seika-Pharma-Invests-in-Lyric-Bio-for-Next-Generation-Human-Immunoglobulin-Manufacturing.webp","datePublished":"2025-12-04T11:27:19+00:00","description":"\u660e\u6cbb\u88fd\u83d3\u304c\u30ea\u30ea\u30c3\u30af\u30d0\u30a4\u30aa\u306b\u6226\u7565\u7684\u8cc7\u672c\u53c2\u52a0\u3001\u6b21\u4e16\u4ee3\u30d2\u30c8\u514d\u75ab\u30b0\u30ed\u30d6\u30ea\u30f3\u88fd\u9020\u3092\u652f\u63f4.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/12\/Meiji-Seika-Pharma-Invests-in-Lyric-Bio-for-Next-Generation-Human-Immunoglobulin-Manufacturing.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/12\/Meiji-Seika-Pharma-Invests-in-Lyric-Bio-for-Next-Generation-Human-Immunoglobulin-Manufacturing.webp","width":1200,"height":800,"caption":"Meiji Seika Pharma"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/meiji-seika-pharma-supports-lyric-bio-in-ig-manufacturing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Meiji Seika Pharma Supports Lyric Bio in Ig Manufacturing"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812","name":"\u30cb\u30e5\u30fc\u30b9\u30c7\u30b9\u30af","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png74f313ad3d6fa27a1eee85c30be63d03","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","caption":"NewsDesk"},"sameAs":["https:\/\/itbusinesstoday.com"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/newsdesk\/"}]}},"authors":[{"term_id":205,"user_id":4,"is_guest":0,"slug":"newsdesk","display_name":"NewsDesk","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png"},"author_category":"","first_name":"NewsDesk","last_name":"","user_url":"https:\/\/itbusinesstoday.com","job_title":"","description":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/24995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=24995"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/24995\/revisions"}],"predecessor-version":[{"id":24997,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/24995\/revisions\/24997"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/24996"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=24995"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=24995"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=24995"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=24995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}